UnitedHealth Group Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) increased by 13.8% to $29.70B in Q4 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An unexplained increase may signal inefficiencies in collections or a buildup of non-core assets, while a decrease generally reflects effective management of miscellaneous receivables.
This represents amounts owed to the company from non-core business activities, excluding standard trade receivables from...
Standard line item across most industries; peers typically group this under other current assets.
current_assets_other_receivables_net_current| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | $26.09B | $29.70B |
| QoQ Change | — | +13.8% |
| YoY Change | — | +13.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.